v3.26.1
Related Party Transactions (Details Narrative) - CAD ($)
12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Statement [Line Items]      
Officers compensation $ 1,171,505 $ 2,708,168 $ 1,525,222
Share-based payments 160,701 1,679,378 465,949
Subscription proceeds   43,100  
Convertible debentures $ 285,311 820,553  
Settlement of outstanding compensation   284,000  
Chief Executive Officers [Member]      
Statement [Line Items]      
Interest rate 6.00%    
Convertible debentures   100,000  
Promissory notes issued $ 411,000    
Maturity date May 31, 2026    
Chief Executive Officers [Member] | December, 2023 [Member]      
Statement [Line Items]      
Subscription proceeds     100,000
Convertible debentures   $ 125,000 $ 125,000
Accrued interest $ 993    
Common shares issued vested     1,000,000
Share purchase warrants 9,930 1,250,000 1,000,000
Conversion of convertible debentures into common shares 9,930 1,250,000  
Chief Executive Officers [Member] | August 2023 [Member]      
Statement [Line Items]      
Subscription proceeds     $ 100,000
Common shares issued vested     1,000,000
Share purchase warrants     1,000,000
Chief Executive Officers [Member] | June 2024 [Member]      
Statement [Line Items]      
Subscription proceeds   $ 50,000  
Common shares issued vested   500,000  
Share purchase warrants   500,000  
Chief Executive Officers [Member] | March 2024 [Member]      
Statement [Line Items]      
Convertible debentures   $ 100,000  
Accrued interest $ 795    
Share purchase warrants 7,950 1,000,000  
Conversion of convertible debentures into common shares 7,950 1,000,000  
Key Management and Director [Member]      
Statement [Line Items]      
Accured interest amount $ 92,797 $ 408,332  
Amounts Due to related party $ 1,415,082 1,476,700  
Interest rate 8.00%    
Subscription proceeds     $ 200,000
Stock options granted during the year     2,000,000
Share purchase warrants     2,000,000
Settlement of outstanding compensation   $ 200,000  
Director and Officers [Member]      
Statement [Line Items]      
Stock option expired 3,590,000   1,480,000
Director, Officers And Former Officer [Member]      
Statement [Line Items]      
Stock options granted during the year 900,000 1,700,000 5,595,000
Accured fees   $ 107,904  
PSU options granted during the year   4,875,000  
MedMelior [Member]      
Statement [Line Items]      
Common Stock Shares Issued   1,893,333  
Stock options granted during the year   1,800,000  
Stock option expired 1,900,000 1,000,000  
Gain on forgiveness of debts     $ (469,129)
Settlement and legal provisions expense   $ 556,640  
Settlement of outstanding compensation   $ 84,000  
Officers And Directors [Member]      
Statement [Line Items]      
Common Stock Shares Issued 10,308,039    
Amounts Due to related party $ 1,030,804